Онкология
2290 статей · 70 журналов
Журналы подкатегории (70)
- EJC Skin Cancer · Elsevier (91)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (90)
- Blood Neoplasia · Elsevier (90)
- The Lancet Oncology · Elsevier (89)
- Cancer Treatment and Research Communications · Elsevier (85)
- European Journal of Surgical Oncology · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (83)
- Brachytherapy · Elsevier (81)
- Cancer Epidemiology · Elsevier (81)
- International Journal of Gynecological Cancer · Elsevier (80)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Lung Cancer · Elsevier (69)
- European Journal of Cancer · Elsevier (68)
- Critical Reviews in Oncology/Hematology · Elsevier (67)
- Leukemia Research Reports · Elsevier (66)
- Surgical Oncology Clinics of North America · Elsevier (66)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (64)
- Gynecologic Oncology Reports · Elsevier (62)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (58)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (54)
- The Journal of Liquid Biopsy · Elsevier (53)
- Leukemia Research · Elsevier (52)
- Cancer Letters · Elsevier (51)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (39)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Current Problems in Cancer: Case Reports · Elsevier (30)
- Journal of Geriatric Oncology · Elsevier (30)
- Journal of Bone Oncology · Elsevier (29)
- Intelligent Oncology · Elsevier (20)
- Precision Radiation Oncology · Wiley (20)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- Best Practice & Research Clinical Haematology · Elsevier (12)
- npj Precision Oncology · Springer Nature (12)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- British Journal of Cancer · Springer Nature (8)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Homozygosity of germ line JAK2 46/1 haplotype contributes to phenotype and outcome diversity in polycythemia vera
- Fenofibrate enhances systemic antitumor efficacy of high- and low-dose radiotherapy plus PD-1 blockade through CD8+ T-cell metabolic reprogramming and LDRT tumor conditioning
- Acquisition of therapeutic resistance and structured tissue differentiation via activation of the life cycle of polyploid giant cancer cells
- Evaluating response criteria in myelodysplastic/myeloproliferative neoplasms: a systematic review and meta-analysis
- Corrigendum to “Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression” [Cancer Lett. 523, (2021), 43–56]
- Emerging immunotherapies in melanoma beyond immune checkpoint inhibitors: Vaccines, intralesional therapies, adoptive cell therapies, and T-cell engagers
- Progress in incidence, mortality, survival, and premature mortality of hepatobiliary cancer overall and by subtype in China 2010–2024: a population-based study
- P0202: Comprehensive Transperineal Prostate Biopsy Positively Impacts Oncologic Outcomes in Low-Dose Rate Prostate Brachytherapy Patients
- P0203: Automating Post-Implant Prostate HDR Brachytherapy Dose Planning Using Deep Learning: A Proof-of-Concept Study
- P0204: Volumetric Stability of the Prostate During Combined HDR Brachytherapy and EBRT
- P0205: Brachytherapy Focal Boost to the Intraprostatic Lesion Using an MRI and US Fusion
- P0206: Fluoroscopy-Guided HDR Interstitial Brachytherapy for Prostate Cancer in Patients with Surgically Absent Recta
- FLT3 (CD135) expression in pediatric AML is associated with distinct features and worse outcomes with sorafenib therapy
- Multilayer modeling reveals an endogenous retrovirus signature predictive of induction chemotherapy failure in AML
- Targeting the integrated stress response to overcome cancer therapy resistance: From mechanisms to therapeutic opportunities
- Drug resistance in breast cancer brain metastasis: mechanisms and therapeutic strategies
- The hypusine circuit: eIF5A at the crossroads of polyamine metabolism, malignant progression, and therapeutic vulnerability
- The senescent tumor microenvironment: Roles in glioblastoma progression
- m6A epitranscriptomic regulation in acute myeloid leukemia: From leukemic dependencies to therapy resistance and therapeutic targeting
- Prostate lymphoma uncovered during urological encounters: Diagnostic challenges and clinical outcomes in a case series with systematic review of the literature
- FOCS-24: An integrated oncologic–functional endpoint and its preoperative nomogram after focal therapy for localized prostate cancer
- Second primary cancer risk after penile squamous cell carcinoma: A population-based study
- Comparing NCCN-based risk groups to the PROTEUS definition of high-risk localized prostate cancer to inform peri-operative care
- Nonmuscle-invasive bladder cancer after solid organ transplantation: Clinical outcomes and recurrence patterns
- Long-term exposure to wildfire-related PM2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study
- Burden of cancer in Africa, 1990–2023: a systematic analysis from the Global Burden of Disease Study 2023
- Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission
- Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population
- Cancer and the microbiome: from association to intervention
- Robotic-assisted bronchoscopic biopsy and EBUS-TBNA in lung cancer: An outcome comparison between clinical and pathological staging